相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IKZF3 deficiency potentiates chimeric antigen receptor T cells targeting solid tumors
Yan Zou et al.
CANCER LETTERS (2022)
GD2-CART cell therapy for H3K27M-mutated diffuse midline gliomas
Robbie G. Majzner et al.
NATURE (2022)
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells
Malgorzata Bajor et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy
Nan Cheng et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice
Ruixin Sun et al.
MOLECULAR THERAPY (2021)
ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models
Tiziana Vaisitti et al.
BLOOD (2021)
Fourth-generation chimeric antigen receptor T cells targeting folate receptor alpha antigen expressed on breast cancer cells for adoptive T cell therapy
Piriya Luangwattananun et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade
Shivani Srivastava et al.
CANCER CELL (2021)
CD27 enhances the killing effect of CAR T cells targeting trophoblast cell surface antigen 2 in the treatment of solid tumors
Huanpeng Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
STING agonist promotes CAR T cell trafficking and in breast cancer
Nuo Xu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The exosomes derived from CAR-T cell efficiently target mesothelin and reduce triple-negative breast cancer growth
Pengxiang Yang et al.
CELLULAR IMMUNOLOGY (2021)
The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice
Qian Zhang et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells
Bo Zhang et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells
Stanley Ly et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Anti-tumor effects of vascular endothelial growth factor/vascular endothelial growth factor receptor binding domain-modified chimeric antigen receptor T cells
Haiyan Xing et al.
CYTOTHERAPY (2021)
PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies
Yamin Jie et al.
FRONTIERS IN IMMUNOLOGY (2021)
B7-H3/CD276: An Emerging Cancer Immunotherapy
Wu-Tong Zhou et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2
Giulia Pellizzari et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Protein Tyrosine Kinase 7 Regulates EGFR/Akt Signaling Pathway and Correlates With Malignant Progression in Triple-Negative Breast Cancer
Nai-Peng Cui et al.
FRONTIERS IN ONCOLOGY (2021)
IL-21 Optimizes the CAR-T Cell Preparation Through Improving Lentivirus Mediated Transfection Efficiency of T Cells and Enhancing CAR-T Cell Cytotoxic Activities
Li Du et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Breast Cancer, Version 4.2021 Featured Updates to the NCCN Guidelines
William J. Gradishar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Recent advances and discoveries in the mechanisms and functions of CAR T cells
Rebecca C. Larson et al.
NATURE REVIEWS CANCER (2021)
In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab
Sara Caratelli et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer
Yuxiang Li et al.
CELLULAR IMMUNOLOGY (2020)
A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts
Gabor Toth et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
AXL as a Target in Breast Cancer Therapy
Sierra A. Colavito
JOURNAL OF ONCOLOGY (2020)
Engineered IL-7 Receptor Enhances the Therapeutic Effect of AXL-CAR-T Cells on Triple-Negative Breast Cancer
Zhenhui Zhao et al.
BIOMED RESEARCH INTERNATIONAL (2020)
T-cells expressing a chimeric-PD1-Dap10-CD3zeta receptor reduce tumour burden in multiple murine syngeneic models of solid cancer
Geoffrey Parriott et al.
IMMUNOLOGY (2020)
Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
Tanja Stuber et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
Johanna Theruvath et al.
NATURE MEDICINE (2020)
Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trial
Yang Liu et al.
CYTOTHERAPY (2020)
Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies
Devikala Gurusamy et al.
CANCER CELL (2020)
Trastuzumab derived HER2-specific CARs for the treatment of trastuzumab-resistant breast cancer: CAR T cells penetrate and eradicate tumors that are not accessible to antibodies
Arpad Szoor et al.
CANCER LETTERS (2020)
Breast cancer: Biology, biomarkers, and treatments
Khadijeh Barzaman et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Gas6/Axl Signaling Pathway in the Tumor Immune Microenvironment
Mai Tanaka et al.
CANCERS (2020)
The Third Generation Anti-HER2 Chimeric Antigen Receptor Mouse T Cells Alone or Together With Anti-PD1 Antibody Inhibits the Growth of Mouse Breast Tumor Cells Expressing HER2in vitroand in Immune Competent Mice
Panyuan Li et al.
FRONTIERS IN ONCOLOGY (2020)
Intercellular Adhesion Molecule-1 as Target for CAR-T-Cell Therapy of Triple-Negative Breast Cancer
Heng Wei et al.
FRONTIERS IN IMMUNOLOGY (2020)
EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo
Lin Xia et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
Novel antibody-drug conjugates for triple negative breast cancer
Aiko Nagayama et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors
Meijia Yang et al.
THERANOSTICS (2020)
Cytokine-Mediated Regulation of CD8 T-Cell Responses During Acute and Chronic Viral Infection
Masao Hashimoto et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2019)
Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting
Shivani Srivastava et al.
CANCER CELL (2019)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
Jiang Lv et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
NR4A transcription factors limit CAR T cell function in solid tumours
Joyce Chen et al.
NATURE (2019)
Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice
Yushu Joy Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies
Lynsey M. Whilding et al.
CANCERS (2019)
Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells
Shengmeng Di et al.
FRONTIERS IN ONCOLOGY (2019)
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Omar Khan et al.
NATURE (2019)
Gene editing for immune cell therapies
Stefanie R. Bailey et al.
NATURE BIOTECHNOLOGY (2019)
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
Ru Zhou et al.
FRONTIERS IN IMMUNOLOGY (2019)
Gangliosides: The Double-Edge Sword of Neuro-Ectodermal Derived Tumors
Sumeyye Cavdarli et al.
BIOMOLECULES (2019)
TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision
Zeyu Chen et al.
IMMUNITY (2019)
IL-17 receptor-based signaling and implications for disease
Xiaoxia Li et al.
NATURE IMMUNOLOGY (2019)
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
Rosalie M. Sterner et al.
BLOOD (2019)
EGFR-specific CAR-T cells trigger cell lysis in EGFR-positive TNBC
Yan Liu et al.
AGING-US (2019)
Lymphocytes in Cellular Therapy: Functional Regulation of CAR T Cells
Dwivedi Alka et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4
Christopher J. Hanley et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4
Christopher J. Hanley et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes
Rokaya El Ansari et al.
BRITISH JOURNAL OF CANCER (2018)
A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers
Jing Wei et al.
CELLULAR IMMUNOLOGY (2018)
Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells
Yali Han et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
Keishi Adachi et al.
NATURE BIOTECHNOLOGY (2018)
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
Margherita Norelli et al.
NATURE MEDICINE (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
Theodoros Giavridis et al.
NATURE MEDICINE (2018)
A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects
Yuki Kagoya et al.
NATURE MEDICINE (2018)
Targeting the tumour stroma to improve cancer therapy
Kenneth C. Valkenburg et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
Stephen J. Bagley et al.
NEURO-ONCOLOGY (2018)
Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice
He Li et al.
CELL DEATH & DISEASE (2018)
Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System
Mauro P. Avanzi et al.
CELL REPORTS (2018)
WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer
Hongming Song et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Wei Wang et al.
CANCER CELL (2018)
Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies
Juliane Gust et al.
CNS DRUGS (2018)
Targeting and suppression of HER3-positive breast cancer by T lymphocytes expressing a heregulin chimeric antigen receptor
Bai-Le Zuo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Improving immune-vascular crosstalk for cancer immunotherapy
Yuhui Huang et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells
Lynsey M. Whilding et al.
MOLECULAR THERAPY (2017)
Therapeutic T cell engineering
Michel Sadelain et al.
NATURE (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
FDA approves first CAR T therapy
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Exploiting poly(I:C) to induce cancer cell apoptosis
Francesca Bianchi et al.
CANCER BIOLOGY & THERAPY (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
Peter Savas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Chimeric antigen receptors: driving immunology towards synthetic biology
Michel Sadelain
CURRENT OPINION IN IMMUNOLOGY (2016)
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
Avery D. Posey et al.
IMMUNITY (2016)
Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies
David T. Rodgers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The Ikaros family of zinc-finger proteins
Yingzhi Fan et al.
ACTA PHARMACEUTICA SINICA B (2016)
Targeting the tumor vasculature to enhance T cell activity
Evripidis Lanitis et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Designing chimeric antigen receptors to effectively and safely target tumors
Michael C. Jensen et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
Ignazio Caruana et al.
NATURE MEDICINE (2015)
CD70: An emerging target in cancer immunotherapy
J. Jacobs et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Engineering CAR-T cells: Design concepts
Shivani Srivastava et al.
TRENDS IN IMMUNOLOGY (2015)
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
Kim C. Ohaegbulam et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Heregulin in Breast Cancer: Old Story, New Paradigm
Ashwani Khurana et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H
Y. Inaguma et al.
GENE THERAPY (2014)
Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
Prasad S. Adusumilli et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
ROR1, an embryonic protein with an emerging role in cancer biology
Nicholas Borcherding et al.
PROTEIN & CELL (2014)
Interleukin-7 receptor-α gene mutations are not detected in adult T-cell acute lymphoblastic leukemia
Uri Rozovski et al.
CANCER MEDICINE (2014)
Construction and evaluation of a novel humanized HER2-specific chimeric receptor
Meili Sun et al.
BREAST CANCER RESEARCH (2014)
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
Christopher C. Kloss et al.
NATURE BIOTECHNOLOGY (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
The many roles of PTK7: A versatile regulator of cell-cell communication
Hanna Peradziryi et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Mesothelin, a novel immunotherapy target for triple negative breast cancer
Julia Tchou et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Role of epidermal growth factor receptor in breast cancer
Hiroko Masuda et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Mechanisms of Leukocyte Transendothelial Migration
William A. Muller
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CDI9-Specific Chimeric Antigen Receptor Redirected T Cells in Humans
Michael C. Jensen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma
Ren Liu et al.
BLOOD (2010)
Anticancer function of polyinosinic-polycytidylic acid
Yu-Sheng Cheng et al.
CANCER BIOLOGY & THERAPY (2010)
The upgraded role of HER3 and HER4 receptors in breast cancer
Angelos K. Koutras et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
The Optimal Antigen Response of Chimeric Antigen Receptors Harboring the CD3ζ Transmembrane Domain Is Dependent upon Incorporation of the Receptor into the Endogenous TCR/CD3 Complex
John S. Bridgeman et al.
JOURNAL OF IMMUNOLOGY (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
The Inducible Costimulator (ICOS) Is Critical for the Development of Human TH17 Cells
Chrystal M. Paulos et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
The role of VEGF in triple-negative breast cancer: where do we go from here?
S. F. Dent
ANNALS OF ONCOLOGY (2009)
Trop2: A possible therapeutic target for late stage epithelial carcinomas
Rafael Cubas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
Mojgan Ahmadzadeh et al.
BLOOD (2009)
Signal integration by JNK and p38 MAPK pathways in cancer development
Erwin F. Wagner et al.
NATURE REVIEWS CANCER (2009)
Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers
Andrea Boni et al.
BLOOD (2008)
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
Brian G. Till et al.
BLOOD (2008)
ErbB-directed immunotherapy:: Antibodies in current practice and promising new agents
Elza Friedlander et al.
IMMUNOLOGY LETTERS (2008)
Harnessing the tumour-derived cytokine, CSF-1, to co-stimulate T-cell growth and activation
Agnes Shuk Yee Lo et al.
MOLECULAR IMMUNOLOGY (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
EGFR associated expression profiles vary with breast tumor subtype
Katherine A. Hoadley et al.
BMC GENOMICS (2007)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
The role of folate receptor α in cancer development, progression and treatment:: Cause, consequence or innocent bystander?
Linda E. Kelemen
INTERNATIONAL JOURNAL OF CANCER (2006)
ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-α-activated vascular endothelium under flow
L Yang et al.
BLOOD (2005)
An inducible caspase 9 safety switch for T-cell therapy
KC Straathof et al.
BLOOD (2005)
The integrin cytoplasmic-tail motif EKQKVDLSTDC is sufficient to promote tumor cell invasion mediated by matrix metalloproteinase (MMP)-2 or MMP-9
MR Morgan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR zeta/CD28 receptor
J Maher et al.
NATURE BIOTECHNOLOGY (2002)
Expression of the αvβ6 integrin promotes migration and invasion in squamous carcinoma cells
GJ Thomas et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
SJ Mandriota et al.
EMBO JOURNAL (2001)
分享论文
